Establishment and validation of an aging-related risk signature associated with prognosis and tumor immune microenvironment in breast cancer

Wang, Zitao; Liu, Hua; Gong, Yiping; Cheng, Yanxiang

doi:10.1186/s40001-022-00924-4

Table 2 The prognosis-related candidate genes via univariate Cox analysis in TCGA

From: Establishment and validation of an aging-related risk signature associated with prognosis and tumor immune microenvironment in breast cancer

Id	HR	HR.95L	HR.95H	P value
UBASH3A	0.78	0.64	0.94	0.01
SLA2	0.78	0.62	0.99	0.04
IL2RG	0.84	0.74	0.95	0.01
LTB	0.84	0.74	0.96	0.01
CD6	0.74	0.60	0.91	0.01
CD247	0.77	0.63	0.94	0.01
PRKCB	0.75	0.58	0.97	0.02
ZAP70	0.77	0.62	0.94	0.01
TNFRSF13C	0.73	0.57	0.95	0.02
STAP1	0.77	0.62	0.96	0.02
PRSS12	0.78	0.62	0.99	0.04
FABP7	0.87	0.77	0.97	0.01
IDO1	0.87	0.77	0.98	0.03
IGHD	0.80	0.71	0.91	0.00
GPR171	0.74	0.61	0.90	0.00
S1PR4	0.75	0.61	0.93	0.00
TNFRSF17	0.83	0.71	0.96	0.01
CD3E	0.82	0.72	0.94	0.00
NKG7	0.86	0.76	0.97	0.02
IGLV1-44	0.89	0.83	0.96	0.00
SPIB	0.80	0.67	0.95	0.01
ASCL1	1.11	1.00	1.23	0.03
IGHG1	0.93	0.87	0.99	0.02
GZMB	0.85	0.74	0.96	0.01
CD40LG	0.75	0.60	0.93	0.01
ITK	0.78	0.63	0.97	0.03
CD79A	0.84	0.75	0.94	0.00
IGHV1-69	0.90	0.82	0.99	0.03
GZMM	0.77	0.64	0.93	0.01
TBX21	0.72	0.54	0.96	0.03
LCK	0.85	0.73	0.99	0.03
TRAV8-3	0.75	0.57	0.97	0.03
SIT1	0.83	0.71	0.97	0.02
PRF1	0.82	0.69	0.99	0.03
CTSW	0.80	0.70	0.92	0.00
IGKC	0.90	0.84	0.96	0.00
LAMP3	0.86	0.75	0.98	0.02
CD79B	0.83	0.70	0.99	0.03
IGHM	0.91	0.85	0.97	0.01
CXCL9	0.91	0.84	0.99	0.02
SIRPG	0.77	0.62	0.94	0.01
TIGIT	0.81	0.67	0.98	0.03
CD7	0.83	0.70	0.99	0.04
IL7R	0.84	0.73	0.96	0.01
SLAMF7	0.85	0.74	0.98	0.02
PLA2G2D	0.81	0.69	0.94	0.00
CLEC10A	0.82	0.70	0.97	0.02
CD3G	0.80	0.67	0.97	0.02
EOMES	0.77	0.61	0.98	0.03
CD5	0.80	0.68	0.95	0.01
CD19	0.81	0.67	0.99	0.04
CD3D	0.82	0.72	0.93	0.00
SEZ6	1.28	1.09	1.50	0.00
S100B	0.85	0.75	0.96	0.01
ICAM3	0.68	0.48	0.95	0.02
TRAV12-2	0.83	0.69	1.00	0.05
ZBED2	0.79	0.65	0.97	0.03
TRAT1	0.80	0.66	0.97	0.02
CXCL1	0.79	0.65	0.96	0.02
TESPA1	0.68	0.52	0.90	0.01
IGLL5	0.88	0.81	0.96	0.00
IGLV6-57	0.88	0.81	0.96	0.00
PYHIN1	0.76	0.60	0.97	0.03
CD27	0.80	0.68	0.93	0.00
CXCR3	0.81	0.69	0.95	0.01
CPLX2	1.19	1.05	1.34	0.01
CD2	0.85	0.75	0.96	0.01
CD96	0.80	0.66	0.97	0.02
SLAMF6	0.80	0.66	0.95	0.01
LGALS2	0.82	0.71	0.94	0.00
GZMK	0.83	0.73	0.95	0.01
PDCD1	0.76	0.62	0.95	0.02
CCL19	0.87	0.81	0.95	0.00
HLA-DOB	0.77	0.64	0.92	0.00
SH2D1A	0.79	0.66	0.95	0.01
CD38	0.82	0.68	0.98	0.03
SLAMF1	0.78	0.61	0.98	0.04
CCL5	0.85	0.77	0.95	0.00

Back to article page

ISSN: 2047-783X

Contact us

Submission enquiries: jacinth.kennady@springernature.com
General enquiries: info@biomedcentral.com

European Journal of Medical Research

Contact us